$CHRN Income Statement | Understand Stock

$CHRN

$14.63 -$0.14 (0.95%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to May 31, 2026	FY2026 12 months to Dec 31, 2025	FY2025 12 months to Dec 31, 2024	FY2024 12 months to Dec 31, 2023	FY2023 12 months to Dec 31, 2022
Revenue
Cost of revenue
Gross profit
Sales and marketing
Research and development
General and Administrative Expense
Total operating expenses
Revenue
Total revenue
Costs and expenses:
Cost of revenues
Selling, general and administrative
Loss (gain) on sale of assets
Total costs and expenses
Operating loss
Gain on revaluation of warrant liabilities
Loss on modification of warrant
Unrealized gain (loss) on foreign exchange
Interest expense, net
Loss on change in fair value of warrants
Other Expense, net
Total other income (expense), net
Net loss from continuing operations before income tax expense
Income tax expense (benefit)
Net loss from continuing operations
Net loss from discontinued operations
Net loss
Foreign currency translation adjustments
Comprehensive loss
Basic and diluted net loss per share attributable to common shareholders
Continuing operations, basic (in dollars per share)
Continuing operations, diluted (in dollars per share)
Discontinued operations, basic (in dollars per share)
Discontinued operations, diluted (in dollars per share)
Basic net loss per share (in dollars per share)
Diluted net loss per share (in dollars per share)
Basic weighted average number of shares outstanding (in shares)
Diluted weighted average number of shares outstanding (in shares)

Comments